Word count: 1,969 words Miyamoto T et al. A novel diagnostic marker, KS 2 ABSTRACT Aims: We previously reported the expression of keratan sulfate (KS), a glycosaminoglycan, in the epithelium of normal and neoplastic endometria. Here, to evaluate its potential use as a diagnostic marker, the expression of KS in other human epithelial tissues was investigated. Methods: The expression was examined immunohistochemically using 102 samples of normal epithelia and 110 samples of carcinomas from the female genital tract (FGT; cervix, endometrium, ovary, fallopian tube), digestive organs (DO; gastrointestinal tract, pancreas, liver), urinary tract (UT), lung, mammary gland, thyroid and mesothelium. Results: In normal tissues, KS was consistently detected in the FGT and ectopic endometrium (25/26), but not found in the DO (1/42) and UT (0/6), and only partial detected in the lung (7/10), mammary gland (3/9) and thyroid (4/4). In malignant tissues, KS was consistently observed in carcinomas of the endometrium, ovary and fallopian tube (29/32), and partially detected in carcinomas of the lung, mammary gland, thyroid, pancreas and mesothelium, but abcent in carcinomas of the gastrointestinal tract (0/17), liver (0/5) and UT (0/11). Among carcinomas of the FGT, DO and UT, KS-positivity suggested the possibility of FGT carcinomas with 79.5% (31/39) sensitivity and 92.9% (39/42) specificity. Conclusions: KS is a potentially useful marker for the supportive diagnosis of the primary site of metastatic carcinomas or unknown primary carcinomas, especially in the abdominal cavity.
INTRODUCTION
Many proteins and lipids are linked to sugar chains to form glycoconjugates including glycoprotein, glycolipid and proteoglycan. Glycoconjugates constitute a large number of cell surface markers in various stages of differentiation with various functions. For instance, blood type antigens and many tumor markers such as CA125 (carbohydrate antigen 125) and CA19-9 are included among cell surface glycoconjugates. [1, 2] Glycosaminoglycans (GAGs) are long unbranched polysaccharide chains consisting of a repeating disaccharide unit. Typically, GAGs are covalently linked to a core protein to form proteoglycans (PGs). PGs hold many water molecules, which function to resist physical pressure. Therefore, GAGs and PGs are important components of connective tissues like cartilage. [3] Keratan sulfate (KS) is a GAG containing a disaccharide unit composed of N-acetylglucosamine and galactose, which are often sulfated. KS is also an important component of the matrix of cartilage, carnea and brain. [3] We previously reported that KS was expressed in the epithelium of eutopic and ectopic endometria and endometrial carcinomas, and suggested the expression to be a potential marker for ectopic endometrium including colonic endometriosis. [4] However, there are few reports of KS expression in the epithelium of normal tissues, or in other neoplastic tissues. Although several histopathological markers such as CA125, cytokeratin (CK) 7 and CK20 are currently used for the supportive diagnosis of tumors, identification of the primary site of a metastatic carcinoma or an unknown primary carcinoma is often difficult. This background indicates KS to be a novel marker for distinguishing tumors originating from the female genital tract (FGT) from carcinomas of other primary sites. Therefore, in the present study, the immunohistochemical expression of KS was extensively investigated in various normal and malignant epithelial tissues to clarify the utility of KS as a diagnostic tool.
MATERIALS AND METHODS

Samples
Formalin-fixed and paraffin-embedded tissue specimens obtained by surgical resection or biopsy were selected from the pathology files of Shinshu University Hospital, and 
Immunohistochemistry
Indirect immunohistochemical staining was performed on paraffin sections using a mouse monoclonal anti-KS antibody, 5D4 (Seikagaku Biobusiness, Tokyo, Japan) (1:
2000), as a primary antibody and a horseradish peroxidase-conjugated goat anti-mouse
IgG antibody (Dako, Glostrup, Denmark) (1: 50) as a secondary antibody. After antigen retrieval by microwave pretreatment, the sections were incubated with the primary antibody and secondary antibody each for 1 hour at room temperature. Then, the immunocomplex bound to KS was visualized by diaminobenzidine. Weak counterstaining was performed with hematoxylin. The same sections were stained with hematoxylin and eosin (HE) for reference.
Evaluation of immunoreactivity
Immunoreactivity was evaluated according to the percentage of positive cells semiquantitatively by two independent reviewers (T.M. and T.S.). No staining in the target cells was defined as negative (-), staining in less than 5% of the cells was defined as weakly positive (+), and staining in more than 5% of the cells was defined as positive (2+). 
RESULTS
The expression of KS in the normal FGT and other epithelial tissues
The expression of KS in carcinomas of other organs
The expression of KS in carcinomas of other organs is also summarized in Fig. 3 . As in normal tissues, no expression of KS was detected in carcinomas of the GIT (Figs. 5a-d In comparison with the FGT and other abdominal organs, the KS expression pattern of carcinomas of the upper FGT including endometrial, ovarian, tubal and peritoneal carcinomas was clearly different from that of the GIT, liver and UT (Fig. 3) .
Among carcinomas of the FGT, DO and UT, KS-positive staining indicated 79.5% (31/39) sensitivity and 92.9% (39/42) specificity for the supportive diagnosis of carcinomas of the FGT (Table 1) . Because the positive rate for KS was lower in cervical carcinomas than other carcinomas of the FGT, sensitivity was calculated excluding cervical carcinomas and was 90.6% (29/32). Also, specificity was calculated without including pancreatic carcinomas and was 100% (33/33). However, the present study revealed that KS was broadly expressed in epithelial cells of Currently, several diagnostic markers such as cytokeratine (CK) 7 and CK20, caudal-type homeobox-2 (CDX-2), estrogen receptor (ER) and CA125 are used for distinguishing between carcinomas of the FGT and those of the gastrointestinal tract. [11] [12] [13] CA125 is one of the most common markers of carcinomas of the FGT, and is thought to be useful for distinguishing these carcinomas from colonic carcinomas. [12] However, CA125 expression was reported to be observed in almost half of pancreatic carcinomas and cholangiocarcinomas, and about 10% of gastric carcinomas. [12] CK7 and CK20 are considered useful for differentiating carcinomas of the FGT from colonic carcinomas; many endometrial or ovarian carcinomas show CK7-positive and CK20-negative staining, but colonic carcinomas are reportedly CK7-negative and CK20-positive. [11, 12] However, these markers are thought unsuitable for distinguishing carcinomas of the FGT from gastric carcinomas or pancreatic carcinomas, [11, 12] because these carcinomas are often CK7-positive and CK20-negative.
CDX2 is known as a highly sensitive and specific marker for colorectal carcinomas, and is not expressed in most carcinomas of the FGT. [12] However, CDX2
was reportedly expressed in approximately 20% of endometrioid type endometrial carcinomas and endometrioid/mucinous type ovarian carcinomas. [14] ER is also known as a specific receptor in gynecological and breast carcinomas. [15, 16] And ER is rarely expressed in the gastrointestinal tract and other DO. [12, 16] However, the sensitivity of this marker may be relatively low. Our previous data revealed that the rate of ER-positive cases in endometrial carcinomas was 69.6%. [15] In comparison with other markers, the sensitivity and specificity of KS against In conclusion, the present study examined the expression of KS in various normal and malignant epithelia, and demonstrated that KS was specifically expressed in FGT in the abdominal organs. Based on the results, we propose the use of KS as a new diagnostic marker. Our data strongly suggested that the immunostaining of KS was particularly useful for distinguishing carcinomas of the FGT (endometrium, ovary and tube) from carcinomas of the GIT, liver and UT, and for the diagnosis of ectopic endometriosis.
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TAKE-HOME MESSAGE
We propose a novel diagnostic marker "Keratan sulfate (KS)" for distinguishing tumors of the female genital tract from those of other primary sites.
KS was commonly expressed in normal and neoplastic epithelia of the female genital tract, but not in the gastrointestinal tract, liver and urinary tract.
In addition, the KS positivity was thought to be useful for the diagnosis of endometriosis at the intestine and/or urinary tract. 
